Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nolver is a Latin American pharmaceutical company dedicated to the development, distribution, and commercialization of high-quality therapeutic solutions. Established in 1994, the company has built a strong presence in regional markets including Venezuela, Uruguay, and Colombia, focusing on therapeutic areas such as the central nervous system, cardiology, and gastroenterology. Nolver's portfolio consists primarily of branded generic medications designed to provide affordable and effective treatment options for chronic and acute conditions. The company operates with a commitment to international quality standards and maintains strategic partnerships to expand its reach within the Andean and Southern Cone healthcare sectors. Nolver is recognized for its robust distribution network and its role as a reliable provider of essential medications in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nolver.